Pay in 4 interest-free payments of $5.35 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
This fixed-rate model eliminates the cost anxiety of traditional tiered pricing systems that penalize dose increases, aligning financial transparency with clinical progression
Semaglutide may also lower your risk of cardiovascular disease and type 2 diabetes since obesity is a major risk factor for both conditions
Participants received once-weekly subcutaneous injections of retatrutide at doses of 0.5 mg, 4 mg, 8 mg, or 12 mg, or placebo, over a 24-week treatment period, with gradual dose escalation to the target maintenance dose
See below for important safety information
US$ 20.37
US$ 23.43
US$ 25.15
US$ 24.13
US$ 29.33
US$ 20.22
US$ 21.81
US$ 21.55
US$ 23.33
